Skip to main content

Coronavirus (COVID-19): Latest Updates | Visitation PoliciesVisitation PoliciesVisitation PoliciesVisitation PoliciesVisitation Policies | COVID-19 Testing | Vaccine InformationVaccine InformationVaccine Information

menu

Jainulabdeen J. Ifthikharuddin, M.D.

Contact Information

Phone Numbers

Appointment: (585) 275-5823

Administrative: (585) 276-3355

Fax: (585) 273-1042

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Locations

James P. Wilmot Cancer Center
601 Elmwood Ave
Rochester, NY 14642

Faculty Appointments

Patient Care Setting

Cancer

Biography

As an oncologist, my goal is to deliver high-quality, comprehensive and compassionate care that is suited to each patient's unique needs.

I have a special interest in the treatment of multiple myeloma and other plasma cell dyscrasias. In addition to my clinical and teaching responsibilities, I am an active participant in several myeloma-related clinical trials.

Conditions I Treat

- Myeloma
- Monoclonal gammopathies
- Amyloidosis

Professional Background

Dr. Ifthikharuddin has a special interest in the treatment of multiple myeloma and other plasma cell dyscrasias. He graduated from the Madras Medical College, India, followed by additional training in the United Kingdom, culminating in diplomas from the Royal College of Physicians (MRCP) and Hematology (MRC Path). He subsequently completed residency training in Internal Medicine and fellowship in Hematology/Oncology at The University of Rochester and joined the faculty in the year 2000. He is board certified in Hematology. In addition to clinical and teaching responsibilities, he is an active participant in several clinical trials.

Research

Dr. Ifthikharuddin has a special interest in the treatment of multiple myeloma and other plasma cell dyscrasias. He graduated from the Madras Medical College, India, followed by additional training in the United Kingdom, culminating in diplomas from the Royal College of Physicians (MRCP) and Hematology (MRC Path). He subsequently completed residency training in Internal Medicine and fellowship in Hematology/Oncology at The University of Rochester and joined the faculty in the year 2000. He is board certified in Hematology. In addition to clinical and teaching responsibilities, he is an active participant in several clinical trials.

Credentials

Specialties

    Education

    1985
    MBBS | Madras Medical College (India)

    Post-doctoral Training & Residency

    08/07/1996 - 08/06/1999
    Fellowship in Hematology & Oncology at University of Rochester Medical Center

    08/10/1994 - 08/06/1996
    Residency in Internal Medicine at University of Rochester Medical Center

    04/26/1985 - 04/25/1986
    Internship at Madras Medical College And Government General Hospital (India)

    VIEW ALL expand_more

    Awards

    2004
    Best Teacher Award
    Sponsor: Hematology/Oncology Fellowship Program
    Location: University of Rochester Medical Center

    1999
    AMGEN Fellowship Grant
    Sponsor: AMGEN

    1997
    Strong Memorial Hospital Innovative Improvement Program
    Sponsor: Strong Memorial Hospital
    Location: Strong Memorial Hospital


    Ad hoc manuscript reviewer
    Sponsor: Journal - Blood Cells, Molecules and Diseases


    Ad hoc manuscript reviewer
    Sponsor: Journal - Thrombosis Research

    VIEW ALL expand_more

    Publications

    Journal Articles

    2013
    Liesveld JL, O'Dwyer K, Walker A, Becker MW, Ifthikaruddin JJ, Mulford D, Chen R, Bechelli J, Roswell K, Minhajuddin M, Jordan CT, Phillips Gl 2nd. "A phase I study of decitabine and rapamycin in relapsed/refractory AML". Leukemia Research. 2013; 37(12): 1662-7.

    2011
    Milner LA; Becker MW; Bernstein SH; Bruckner L; Friedberg JW; Holland GA; Ifthikharuddin JJ; LIesveld JL; Mathes EJ; Mechel HL; Mullen CA; Sasson T; Phillips GL 2nd. "Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease". Am J Hematology. 2011; 86(8): 712-714.

    2011
    Liesveld JL; Rosell KE; Bechelli J; Lu C; Messina P; Mulford D; Ifthikharuddin JJ; Jordan CT; Phillips GL 2nd. "Proteasome inhibition in myelodysplastic syndromes and acute myelogeneous leukemia cell lines". Cancer Invest. 2011; 29(7): 438-450.

    Books & Chapters

    1999
    Chapter Title: Introduction-Type C oncoviruses including human T-cell lymphotropic types I and II
    Book Title: Principles and Practice of Infectious Diseases
    Author List: Ifthikharuddin, JJ; Rosenblatt, JD
    Edited By: Mandell, GL; Bennett, JE; Dolin, R
    Published By: Churchill Livingston 1999 in New York

    VIEW ALL PUBLICATIONS